Summary of Use during Lactation

No information is available on the use of solriamfetol during breastfeeding. If solriamfetol is required by the mother, it is not a reason to discontinue breastfeeding. Monitor the breastfed infant for adverse reactions, such as agitation, insomnia, poor feeding, and reduced weight gain.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

(Narcolepsy) Amphetamine, Armodafinil, Dextroamphetamine, Lisdexamfetamine, Methylphenidate, Modafinil, Oxybate Salts, Pitolisant

Substance Name

Solriamfetol

CAS Registry Number

178429-62-4

Drug Class

Breastfeeding

Lactation

Milk, Human

Adrenergic Agents

Carbamates

Central Nervous System Stimulants

Dopamine Agents

Wakefulness-Promoting Agents